UK "ethical red tape" is stifling research

13 August 2006

UK researchers are complaining that ethical standards and adminstrative hurdles introduced after a scandal involving a National Health Service hospital, have damaged medical research in the country.

Jenny Hewison, a clinical researcher at Leeds University, told the UK's Guardian newspaper that it is "a disaster and it is absolutely not in the public interest." Dr Hewison and Andy Haines, a colleague at the London School of Hygiene and Tropical Medicine, have written to the British Medical Journal to raise concerns about the unintended effects of new regulations.

800 infants' body parts taken

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight